Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 13Recruiting 4Unknown 3Terminated 3Active not recruiting 2

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 62Breast 41Sarcoma 25Gastrointestinal 18Other hematologic neoplasm 17Plasma cell 8CNS 6Thoracic 4Gynecologic 4Other solid neoplasm 3Genitourinary 3Myeloid 2Dermatologic 2Tumor-Agnostic 1

Conditions

Mesothelioma, Malignant 2Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Doxorubicin × Other solid neoplasm × Clear all
NCT00005024 2014-01-06

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

National Cancer Institute (NCI)

Phase 3 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00024271 2014-01-06

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00003034 2013-11-06

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡